• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: New Insights into Cisplatin Distribution During HIPEC from a Porcine Model.

作者信息

Harlev Christina, Bue Mats, Petersen Elisabeth Krogsgaard, Jørgensen Andrea René, Bibby Bo Martin, Hanberg Pelle, Schmedes Anne Vibeke, Petersen Lone Kjeld, Stilling Maiken

机构信息

Department of Clinical Medicine, Aahrus University, Aarhus, Denmark.

Orthopaedic Research Laboratory, Aahrus Denmark Microdialysis Research (ADMIRE), Aahrus University Hospital, Aarhus, Denmark.

出版信息

Ann Surg Oncol. 2025 Jun;32(6):4526-4527. doi: 10.1245/s10434-025-17171-6. Epub 2025 Apr 3.

DOI:10.1245/s10434-025-17171-6
PMID:40178673
Abstract
摘要

相似文献

1
ASO Author Reflections: New Insights into Cisplatin Distribution During HIPEC from a Porcine Model.ASO作者反思：来自猪模型的腹腔热灌注化疗期间顺铂分布的新见解。
Ann Surg Oncol. 2025 Jun;32(6):4526-4527. doi: 10.1245/s10434-025-17171-6. Epub 2025 Apr 3.
2
ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy.ASO作者反思：顺铂腹腔热灌注化疗改善新辅助化疗后晚期卵巢癌的预后
Ann Surg Oncol. 2022 Apr;29(4):2626-2627. doi: 10.1245/s10434-021-11120-9. Epub 2022 Jan 3.
3
ASO Author Reflections: Advancing Gastric Cancer Treatment Through HIPEC-Current Insights and Future Directions.《美国外科医师学会作者反思：通过腹腔热灌注化疗推进胃癌治疗——当前见解与未来方向》
Ann Surg Oncol. 2025 Jan;32(1):252-253. doi: 10.1245/s10434-024-16372-9. Epub 2024 Oct 28.
4
ASO Author Reflections: Evaluating HIPEC Switch for Repeat CRS-HIPEC, Time to End a Common Practice?美国外科肿瘤学会作者反思：评估用于重复细胞减灭术-热灌注化疗的热灌注化疗转换装置，是时候终止一种常见做法了吗？
Ann Surg Oncol. 2023 Jan;30(1):392-393. doi: 10.1245/s10434-022-12483-3. Epub 2022 Sep 6.
5
ASO Author Reflections: Evolving Paradigms in the Management of Peritoneal Metastases Recurrences: Repeat Cytoreductive Surgery with HIPEC or Not-Insights from French Expert Centers.ASO作者反思：腹膜转移复发管理中的不断演变的范式：是否进行高剂量腹腔内热灌注化疗辅助的重复细胞减灭术——来自法国专家中心的见解
Ann Surg Oncol. 2025 Feb;32(2):707-708. doi: 10.1245/s10434-024-16563-4. Epub 2024 Nov 20.
6
Dynamic Assessment of Local Abdominal Tissue Concentrations of Cisplatin During a HIPEC Procedure: Insights from a Porcine Model.热灌注化疗术中顺铂局部腹部组织浓度的动态评估：来自猪模型的见解
Ann Surg Oncol. 2025 May;32(5):3804-3813. doi: 10.1245/s10434-025-17000-w. Epub 2025 Feb 12.
7
ASO Author Reflections: Reflections on the Impact of Access to CRS/HIPEC via Medicaid Expansion as a Key to Future Models for Advanced Surgical Cancer Care.美国外科医师学会作者反思：关于通过医疗补助扩大计划获得细胞减灭术/腹腔热灌注化疗对晚期外科癌症护理未来模式的影响的反思。
Ann Surg Oncol. 2025 Apr;32(4):2940-2941. doi: 10.1245/s10434-024-16556-3. Epub 2025 Jan 5.
8
ASO Author Reflections: Economics of Experience-Institutional Learning Curve of CRS-HIPEC.ASO作者反思：CRS-HIPEC的经验经济学——机构学习曲线
Ann Surg Oncol. 2024 Dec;31(13):8602-8603. doi: 10.1245/s10434-024-16093-z. Epub 2024 Sep 25.
9
ASO Author Reflections: Advancing Post-operative Infection Risk Assessment of CRS/HIPEC with Splenectomy.ASO作者反思：推进脾切除术后CRS/HIPEC的术后感染风险评估
Ann Surg Oncol. 2025 Apr;32(4):2934-2935. doi: 10.1245/s10434-024-16825-1. Epub 2024 Dec 30.
10
ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.ASO作者反思：腹膜转移的姑息治疗——探索CRS/HIPEC的风险与益处，这与具有“治愈意图”的早期CRS/HIPEC干预背景截然不同。
Ann Surg Oncol. 2022 May;29(5):3347-3348. doi: 10.1245/s10434-022-11377-8. Epub 2022 Feb 25.

本文引用的文献

1
Dynamic Assessment of Local Abdominal Tissue Concentrations of Cisplatin During a HIPEC Procedure: Insights from a Porcine Model.热灌注化疗术中顺铂局部腹部组织浓度的动态评估：来自猪模型的见解
Ann Surg Oncol. 2025 May;32(5):3804-3813. doi: 10.1245/s10434-025-17000-w. Epub 2025 Feb 12.
2
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.细胞减灭术联合或不联合腹腔热灌注化疗治疗晚期卵巢癌患者（OVHIPEC-1）：一项随机对照 3 期临床试验的最终生存分析。
Lancet Oncol. 2023 Oct;24(10):1109-1118. doi: 10.1016/S1470-2045(23)00396-0. Epub 2023 Sep 11.
3
Peritoneal Carcinomatosis from Ovarian Cancer - Current Clinical Impact of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy.
卵巢癌所致腹膜癌转移——肿瘤细胞减灭术及腹腔内热化疗的当前临床影响
Klin Onkol. 2019 Fall;32(5):349-352. doi: 10.14735/amko2019349.